Cleared Traditional

K223915 - Tactoset

K223915 is an FDA 510(k) clearance for Tactoset, manufactured by Anika Therapeutics, Inc.. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K223915 · Anika Therapeutics, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
90d
Days
Class 2
Risk

K223915 is an FDA 510(k) clearance for the Tactoset. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Anika Therapeutics, Inc. (Beford, US). The FDA issued a Cleared decision on March 29, 2023 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Anika Therapeutics, Inc. devices

FDA 510(k) Submission Details - K223915

510(k) Number K223915 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 29, 2022
Decision Date March 29, 2023
Days to Decision 90 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 122d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 290
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K223915.
Mineral Collagen Composite Bioactive Extra Moldable
K231942 · Collagen Matrix, Inc. · Aug 2023
Graftys Quickset
K231714 · Graftys · Jul 2023
Bonalive Orthopedics granules
K231528 · Bonalive Biomaterials, Ltd. · Jul 2023
DSM Biomedical Calcium Phosphate Cement
K230054 · Dsm Biomedical · Mar 2023
GaiaBone Bioabsorbable Bone Graft
K220337 · Corliber (Shenzhen) Medical Device Co., Ltd. · Feb 2023
MONTAGE Settable, Resorbable Bone Putty
K222063 · Orthocon, Inc. · Feb 2023